E-MAIL UPDATES

Click here to join
our Electronic Communications.

Investors & Media

Whats new.

Press releases

Press releases.

Immutep Announces European Patent Grant for LAG525 Antibody

November 13th 2019
press releases

Immutep Presents Positive Interim Data from Phase II TACTI-002 Trial at SITC

November 7th 2019
press releases

IMMUTEP AGM 2019 - Chairman's Address

November 1st 2019
press releases
more

Investor updates

Investor updates.

Investor Update - November 2019

November 22nd 2019
investor updates

Investor Update - January 2019

January 31st 2019
investor updates

Investor Update - June 2018

June 19th 2018
investor updates
more

Analyst reports

Analyst reports.

Maxim - Runway Through CY20, Upcoming Catalysts ShouldContinue to Drive a Higher Valuation

October 28th 2019
analyst reports

goetzpartners securities - TACTI-mel final data confirm efficacy signals

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

October 15th 2019
analyst reports

goetzpartners securities - Positive interim analysis for TACTI-002

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

September 26th 2019
analyst reports
more